PROTOCOL ACTIVATION
GYNECOLOGIC

NRG-GY016: "A Phase II Study of MK-3475 (Pembrolizumab) (NSC #776864) + Epacadostat (NSC #766086) in Recurrent Clear Cell Carcinoma of the Ovary.”

NCI Version Date: July 5, 2018

Activation Date: September 28, 2018

Documents will be available on the CTSU website shortly.

 

 

Twitter

Four Penn Center 1600 JFK Blvd. Suite1020 , Philadelphia, PA, 19103


Update Profile/Email Address